In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species
Author(s) -
A L Barry,
Steven D. Brown
Publication year - 1996
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.40.8.1948
Subject(s) - voriconazole , fluconazole , triazole , antifungal , microbiology and biotechnology , in vitro , biology , fungicide , pharmacology , chemistry , biochemistry , botany , organic chemistry
A new triazole derivative (voriconazole or UK-109,496) and fluconazole were tested against 249 isolates of Candida spp. representing six species. Voriconazole was 10 to 100 times more potent than fluconazole. Strains with decreased susceptibility to fluconazole were inhibited by relatively low concentrations of voriconazole.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom